AAAAAA

   
Results: 1-7 |
Results: 7
Interleukin 12 delays allograft rejection: Effect mediated via nitric oxide
Authors: Verma, N He, XY Chen, J Robinson, C Boyd, R Tran, G Hall, BM
Citation: N. Verma et al., Interleukin 12 delays allograft rejection: Effect mediated via nitric oxide, TRANSPLAN P, 33(1-2), 2001, pp. 416-417
IL-4 therapy prevents the development of proteinuria in active heymann nephritis by inhibition of tel cells
Authors: Spicer, ST Ha, H Boyd, RA He, XY Carter, N Tran, G Penny, MJ Hodgkinson, SJ Hall, BM
Citation: St. Spicer et al., IL-4 therapy prevents the development of proteinuria in active heymann nephritis by inhibition of tel cells, J IMMUNOL, 167(7), 2001, pp. 3725-3733
Preoperative nutritional evaluation of elderly patients: the Mini Nutritional Assessment as a practical tool
Authors: Cohendy, R Gros, T Arnaud-Battandier, F Tran, G Plaze, JM Eledjam, JJ
Citation: R. Cohendy et al., Preoperative nutritional evaluation of elderly patients: the Mini Nutritional Assessment as a practical tool, CLIN NUTR, 18(6), 1999, pp. 345-348
Pharmacokinetics, metabolism and bioavailability of the new anti-allergic drug BM 113 Part III: Pharmacokinetics, metabolism, dose dependancy and gender effect after single or repeated administration to human healthy volunteers
Authors: Duchene, P Laneury, JP Tran, G Ladure, P Ollivier, P Buzas, A Merour, JY Houin, G
Citation: P. Duchene et al., Pharmacokinetics, metabolism and bioavailability of the new anti-allergic drug BM 113 Part III: Pharmacokinetics, metabolism, dose dependancy and gender effect after single or repeated administration to human healthy volunteers, ARZNEI-FOR, 49(8), 1999, pp. 699-704
Pharmacokinetics, metabolism and bioavailability of the new anti-allergic drug BM 113 - Part II: Pharmacokinetics in primates after repeated oral or single intravenous administration
Authors: Duchene, P Guidicelli, MD Tran, G Ladure, P Ollivier, R Buzas, A Merour, JY Houin, G
Citation: P. Duchene et al., Pharmacokinetics, metabolism and bioavailability of the new anti-allergic drug BM 113 - Part II: Pharmacokinetics in primates after repeated oral or single intravenous administration, ARZNEI-FOR, 49(7), 1999, pp. 608-611
Pharmacokinetics, metabolism and bioavailability of the new anti-allergic drug BM 113 part 1: Pharmacokinetics and tissular distribution in Sprague-Dawley rats
Authors: Duchene, P Tran, G Ladure, P Ollivier, R Buzas, A Merour, JY Houin, G
Citation: P. Duchene et al., Pharmacokinetics, metabolism and bioavailability of the new anti-allergic drug BM 113 part 1: Pharmacokinetics and tissular distribution in Sprague-Dawley rats, ARZNEI-FOR, 49(6), 1999, pp. 504-508
Continuous epidural infusion of ropivacaine for postoperative analgesia after major abdominal surgery: comparative study with iv PCA morphine
Authors: Jayr, C Beaussier, M Gustafsson, U Leteurnier, Y Nathan, N Plaud, B Tran, G Varlet, C Marty, J
Citation: C. Jayr et al., Continuous epidural infusion of ropivacaine for postoperative analgesia after major abdominal surgery: comparative study with iv PCA morphine, BR J ANAEST, 81(6), 1998, pp. 887-892
Risultati: 1-7 |